Former Health and Human Services secretary Alex Azar, who spent a decade with pharmaceutical giant Eli Lilly and Co, has now become the chairman of the board of a company trying to make prescription drug imports happen. The company, LifeScience Logistics, is managing Florida’s Canadian importation program and is being paid $39 million by the Florida government to buy drugs from Canadian suppliers. This move has raised concerns of potential conflicts of interest, as Azar had previously certified the safety of drugs imported from Canada, a policy opposed by the U.S. drug industry. The FDA recently approved Florida’s first-in-the-nation import plan, but it still faces many hurdles, including opposition from the Canadian government and drug manufacturers.
Source link
Alex Azar’s Unusual Spin Through the Revolving Door
